Quotient Wealth Partners LLC Has $308,000 Stake in Cigna Group $CI

Quotient Wealth Partners LLC lifted its position in shares of Cigna Group (NYSE:CI) by 7.3% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 931 shares of the health services provider’s stock after purchasing an additional 63 shares during the quarter. Quotient Wealth Partners LLC’s holdings in Cigna Group were worth $308,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of CI. Brighton Jones LLC raised its position in shares of Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after purchasing an additional 318 shares during the period. GAMMA Investing LLC grew its holdings in Cigna Group by 79.0% during the first quarter. GAMMA Investing LLC now owns 5,394 shares of the health services provider’s stock worth $1,775,000 after buying an additional 2,381 shares in the last quarter. CWA Asset Management Group LLC grew its holdings in Cigna Group by 17.8% during the first quarter. CWA Asset Management Group LLC now owns 932 shares of the health services provider’s stock worth $306,000 after buying an additional 141 shares in the last quarter. Boston Trust Walden Corp bought a new stake in Cigna Group during the first quarter worth $233,000. Finally, Blue Trust Inc. grew its holdings in Cigna Group by 16.4% during the first quarter. Blue Trust Inc. now owns 2,245 shares of the health services provider’s stock worth $739,000 after buying an additional 316 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently issued reports on CI shares. Truist Financial set a $375.00 price target on Cigna Group in a report on Tuesday, September 2nd. Deutsche Bank Aktiengesellschaft set a $415.00 price target on Cigna Group and gave the stock a “buy” rating in a report on Tuesday, August 5th. Wall Street Zen downgraded Cigna Group from a “buy” rating to a “hold” rating in a report on Friday, October 3rd. The Goldman Sachs Group started coverage on Cigna Group in a research note on Tuesday. They issued a “buy” rating and a $370.00 price objective for the company. Finally, Wolfe Research reduced their price objective on Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $369.89.

Cigna Group Stock Up 3.0%

Shares of NYSE CI opened at $299.81 on Friday. Cigna Group has a one year low of $256.89 and a one year high of $353.55. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The business’s fifty day moving average price is $297.27 and its 200-day moving average price is $308.13. The stock has a market capitalization of $80.03 billion, a PE ratio of 16.37, a P/E/G ratio of 0.88 and a beta of 0.45.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm had revenue of $67.13 billion for the quarter, compared to analysts’ expectations of $62.61 billion. During the same quarter in the prior year, the firm earned $6.72 EPS. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities research analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were given a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date of this dividend was Thursday, September 4th. Cigna Group’s dividend payout ratio is currently 32.97%.

Insiders Place Their Bets

In other news, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider owned 51,182 shares of the company’s stock, valued at $15,354,600. This represents a 9.49% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares in the company, valued at $7,694,400. This trade represents a 52.66% decrease in their position. The disclosure for this sale can be found here. 0.70% of the stock is owned by corporate insiders.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.